| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

* From the Department of Anesthesia, and Clinical Research Support Unit,
British Columbias Childrens Hospital and the University of British Columbia, Vancouver, British Columbia, Canada.
Address correspondence to: Dr. Carolyne Montgomery, British Columbias Childrens Hospital, 4480 Oak Street, Vancouver, British Columbia V6H 3V4, Canada. Phone: 604-875-2711; Fax: 604-875-3221; E-mail: cmontgomery{at}cw.bc.ca
| Abstract |
|---|
|
|
|---|
Methods: After Ethics Committee approval and informed written parental consent, 127 children, aged one to ten years were studied and randomized into two groups; Group P/L received an induction with 5 mgkg-1 of 1% propofol and 1 mgkg-1 of lidocaine, Group P/T with 3 mgkg-1 of 1% propofol and 3 mgkg-1 of 2.5% thiopentone in a standardized fashion. A single, blinded observer scored pain behaviour defined as a motor response of the arm, a verbal complaint of pain, cry and/or one of three standardized facial expressions of pain.
Results: The incidence of pain was 14% in the P/T group, compared to 35% in the P/L group (
21 = 7.5, P = 0.006). Motor response was the most frequent pain response in the P/L group (68%).
Conclusion: The P/T admixture is a practical and efficacious alternative to P/L for reducing pain on induction in children. Further work to evaluate the optimum proportions and possible adverse effects of this admixture should be done.
| Introduction |
|---|
|
|
|---|
The incidence of pain on injection of propofol has been extensively studied and ranges from 50100%.3 A mainly adult meta-analysis of this clinical problem concludes that the optimum treatment is to give iv lidocaine 0.5 mgkg-1 while a tourniquet is applied to the arm for at least 30120 sec prior to the injection of the propofol.4 This recommendation is, in our view, impractical in the pediatric population.
Pediatric studies describe a high incidence of pain on injection (50%) when propofol alone is injected into a vein on the dorsum of the hand.5 A routinely used technique to reduce the pain on injection in children is to admix preservative-free lidocaine in a dose of 1 mgkg-1 with an induction dose of propofol 5 mgkg-1. The efficacy of this technique in a study of 50 children was 100%.6 In an unblinded, observational pilot study of 50 children using this technique at our institution, the incidence of pain was 20%.
The admixture of thiopentone and propofol may also reduce injection pain. Adult studies using thiopentone demonstrated that pretreating a vein with 50 mg of thiopentone prior to propofol injection was not as efficacious in reducing injection pain as 40 mg of lidocaine.7 In contrast, pretreating with 100 mg thiopentone was more effective than 20 mg of lidocaine.8 In children, pretreatment with 3 mgkg-1 of thiopentone prior to injecting propofol 1.5 mgkg-1 with lidocaine 0.075 mgkg-1 reduced the injection pain from 81% to 27%.9 A 1:1 and 3:1 admixture of 1% propofol and 2.5% thiopentone (23% and 37% pain respectively) were superior to propofol and lidocaine in a 5:1 ratio (40% pain) in relieving pain on injection in adults.10
We hypothesized that the incidence of pain on injection during anesthetic induction with an admixture of 1% propofol, 3 mgkg-1 and 2.5% thiopentone, 3 mgkg-1 (P/T) would be less than that with an admixture 1% propofol, 5 mgkg-1 and 2% lidocaine, 1 mgkg-1 of (P/L).
| Methods |
|---|
|
|
|---|
40 kg, were invited to participate in the study. Subjects who had a body mass index > 30, or an allergy to any of the local anesthetics, analgesics or induction agents, or who did not receive acetaminophen preoperatively were excluded. Any child who had cognitive-behavioural disturbances or a parent or caregiver who could not be present at induction was also excluded from the study.
Randomization was achieved using a computer generated random numbers table and randomizing in blocks of ten. The induction sequence of events was standardized (see Appendix 1). Any subject who was not calm and cooperative immediately prior to induction or responded "No" to the question "Does your hand feel OK?" after establishment of iv access and prior to induction was excluded from further study.
Demographic data including the age, weight and gender of the subjects were recorded. The time from administration of a preoperative oral dose of acetaminophen 20 mgkg-1 to induction was recorded.
Group P/L received 1% propofol, 5 mgkg-1 mixed with 2% lidocaine, 1 mgkg-1. Group P/T received 1% propofol, 3 mgkg-1 mixed with 2.5% thiopentone, 3 mgkg-1.
The study drugs were prepared immediately prior to induction by the staff anesthesiologist not involved in the observations. The syringes were visually indistinguishable. Pain was recorded as a dichotomous variable, yes or no. Intensity was not evaluated. A yes was scored when any one of the following pain outcomes occurred: verbal, motor, facial action and cry (see Appendix 2).
Sample size was calculated for the primary outcome, pain. Based on a pilot study of 50 patients, it was estimated that the incidence of pain on injection of P/L was 20%. In order to detect an 18% decrease in pain in the P/T group with 0.8 power and type one error of 0.5, 62 subjects were randomized to each group. This number of subjects was sufficient to achieve an estimate of the difference in pain incidence with confidence intervals (CI) of width 20%.
The statistical package, SPSS (version 10.0), was used to analyze the data. Demographic data are presented as either percent, mean ± SD, or median and range. The two blinded observers (JMcF/RP) independently scored the first 11 patients to test for agreement between observers. An assessment to ensure agreement between observers was carried out using the Kappa statistic. A single observer scored the rest of the subjects (RP).
The primary outcome of pain in each group was analyzed using the Pearsons Chi squared test statistic. Logistic regression was used to explore the influences of appropriateness of acetaminophen to induction time and group (P/L vs P/T) on pain.
| Results |
|---|
|
|
|---|
The age, weight and gender of the 127 subjects (P/L = 63, P/T = 64) in the two treatment groups were similar (Table I
). The acetaminophen administration-to-induction times were also similar in the two groups (Table I
). There was a wide range in these times due to scheduling issues. In 115 (90%) subjects, venous cannulation was achieved on the first attempt. In 12 (9%) subjects multiple attempts were required. Despite multiple attempts at cannulation, these few subjects were calm, did not report hand pain prior to induction and were thus eligible to continue with the study. One subject in each group proceeded to give a positive pain response during the iv injection.
|
|
21 = 7.5, P = 0.006). Motor response occurred more frequently in the P/L group (68%). No subject demonstrated facial action alone. Cry occurred in seven (25%) subjects who concurrently demonstrated other positive pain variables, and in one subject as a sole pain score. The distribution of pain responses for each subject is shown in the Figure.
Acetaminophen administration to induction time was subdivided into inadequate (
30 min,
90 min) and adequate (3090 min) and the relationship between these two groups and the primary outcome, pain, was investigated by logistic regression. Controlling for acetaminophen administration time did not affect the relationship between pain and group. The P/L group was still more likely to experience pain [odds ratio = 3.37, 95% CI = (1.40, 8.15)].
| Discussion |
|---|
|
|
|---|
The efficacy of lidocaine in doses of 0.11.0 mgkg-1 in reducing pain on injection in children ranges from 21100% in various studies (Table III
). Previous investigators using composite pain outcome measures (cry, self report, arm withdrawal and grimace) have concluded that the efficacy of lidocaine appears to be best in a dose of 1 mgkg-1.6 With our outcome measure, the efficacy of this technique was 66%. Although accurate pain measurement is very challenging in children, our composite dichotomous score based on any one of verbal self-report, motor responses, three robust facial expressions and cry measured a clinically relevant difference. While this tool is not a recognized one, it was devised by our group based on our pre-clinical trial and had good inter-observer agreement over the initial 11 patients in this study. The apparently most robust elements of this tool were motor response of arm or hand withdrawal, reaching for the arm and self-report of pain in a previously calm and distracted child. These were the outcome variables that we observed in 93% of subjects having pain. Age and the ability to self-report was a factor in this study. Older children were able to respond to the phrases more often.
|
While facial action has been studied previously in children in recovery room situations, it has not been validated for this particular pain model.14 We elected to choose what might be considered the more robust facial actions of brow lower, eye squeeze, and cheek raiser. It was beyond the resources of our group to provide multiple observers, videotaping and fully trained facial action raters for each subject. Interestingly, none of these facial actions occurred without concurrent positive behaviours. Cry was also considered valid in this setting as no subjects were crying after venous cannulation and prior to start of the injection. Cry may be a non-specific behaviour and only occurred in isolation in one subject. No effort was made to assign an intensity rating to any of these pain behaviours. A valid pain outcome measure for use in this setting is required.
The speed of injection has been implicated as a factor in the incidence of injection pain.2,15 A meta-analysis by Picard found no correlation between speed of injection and the incidence of pain.3 We standardized the duration of administration. After an initial dose of 0.1 mLkg-1, five seconds elapsed to allow the subject time to experience and report any possible pain. This technique also presumably standardized the degree of sedation.
The P/T admixture may be less painful to inject simply because propofol is diluted. Propofol diluted 1:1 with 5% dextrose caused significantly less injection pain.16 Diluting propofol with a 2:1 lipid emulsion reduced injection pain more successfully than a 2:1 admixture with saline1 suggesting that it is the amount of propofol in the aqueous phase that causes the pain. Both these studies diluted the propofol significantly more than our 3:1 thiopentone admixture. The method by which pain is reduced may be due to the high pH of the admixture driving the propofol from aqueous phase into lipid phase. The effect of thiopentone on the surface tension properties of the propofol oil/water interface also needs further evaluation.10 The optimum ratio of dilution of propofol with thiopentone may not be 3:1 and requires a dose-finding study evaluating in detail the efficacy and side-effects of other ratios of admixtures.
The P/T admixture has the advantages of stability,17,18 less support of bacterial growth,1921 no change in recovery profile,22 and decreased expense. In our institution, July 2001, in Canadian currency, for a 20 kg patient, propofol 3 mgkg-1 and thiopentone 3 mgkg-1 costs $1.60, whereas propofol 5 mgkg-1 and lidocaine 1 mgkg-1 costs $2.80; approximately 60% less. The elimination of the local anesthetic, lidocaine during induction, may add a margin of safety when other local anesthetics are used at a maximum dose for regional anesthesia. It was beyond the scope of this study to examine in detail any disadvantages to the use of this admixture.
Despite the use of the oral analgesic, acetaminophen as a premedicant, the incidence of pain was significant in the P/L group, 35%. As acetaminophen was used in both groups the incidence of pain may be even higher when this premedicant is not given.
Limitations: the hemodynamic effects, immediate in-hospital or late recovery profile and incidence of postoperative nausea and vomiting of these admixtures were not evaluated in this study. In summary, the use of an admixture of 1% propofol, 3 mgkg-1 and 2.5% thiopentone, 3 mgkg-1 (P/T) compared to an admixture of 1% propofol, 3 mgkg-1 and 2% lidocaine, 1 mgkg-1 (P/L) reduced the pain on injection at induction of anesthesia in pediatric patients from 34% to 14%. The propofol and thiopentone admixture is a practical and efficacious alternative to propofol and lidocaine for reducing pain on injection.
| APPENDIX 1 Standardized induction sequence |
|---|
|
|
|---|
| APPENDIX 2 Pain outcomes |
|---|
|
|
|---|
|
| Acknowledgments |
|---|
| Footnotes |
|---|
Internally supported investigation with no grant or independent funding.
Revision received August 26, 2002. Accepted for publication April 29, 2002.
| References |
|---|
|
|
|---|
2 Scott RP, Saunders DA, Norman J. Propofol: clinical strategies for preventing the pain of injection. Anaesthesia 1988; 43: 4924.[Medline]
3 Picard P, Tramer MR. Prevention of pain on injection with propofol: a quantitative systematic review. Anesth Analg 2000; 90: 9639.
4 Mangar D, Holak EJ. Tourniquet at 50 mm Hg followed by intravenous lidocaine diminishes hand pain associated with propofol injection. Anesth Analg 1992; 74: 2502.[Medline]
5 Morton NS, Wee M, Christie G, Gray IG, Grant IS. Propofol for induction of anaesthesia in children. A comparison with thiopentone and halothane inhalational induction. Anaesthesia 1988; 43: 3505.[Medline]
6 Morton NS. Abolition of injection pain due to propofol in children (Letter). Anaesthesia 1990; 45: 70.
7 Haugen RD, Vaghadia H, Waters T, Merrick PM. Thiopentone pretreatment for propofol injection pain in ambulatory patients. Can J Anaesth 1995; 42: 110812.
8 Lee TW, Loewenthal AE, Strachan JA, Todd BD. Pain during injection of propofol. The effect of prior administration of thiopentone. Anaesthesia 1994; 49: 8178.[Medline]
9 Cheng KI, Tang CS, Chiu SL, et al. Injection pain with propofol. The effectiveness of thiopentone on induction. Kaohsiung J Med Sci 1998; 14: 4805.[Medline]
10 Jones, D, Prankerd R, Lang C, Chilvers M, Bignell S, Short T. Propofol-thiopentone admixturehypnotic dose, pain on injection and effect on blood pressure. Anaesth Intensive Care 1999; 27: 34656.[Medline]
11 Hannallah RS, Baker SB, Casey W, McGill WA, Broadman LM, Norden JM. Propofol: effective dose and induction characteristics in unpremedicated children. Anesthesiology 1991; 74: 2179.[Medline]
12 Cameron E, Johnston G, Crofts S, Morton NS. The minimum effective dose of lignocaine to prevent injection pain due to propofol in children. Anaesthesia 1992; 47: 6046.[Medline]
13 Valtonen M, Iisalo E, Kanto J, Rosenberg P. Propofol as an induction agent in children: pain on injection and pharmacokinetics. Acta Anaesthesiol Scand 1989; 33: 1525.[Medline]
14 Gilbert CA, Lilley CM, Craig KD, et al. Postoperative pain expression in preschool children: validation of the child facial coding system. Clin J Pain 1999; 15: 192200.[Medline]
15 Huang CL, Wang YP, Cheng YJ, Susetio L, Liu CC. The effect of carrier intravenous fluid speed on the injection pain of propofol. Anesth Analg 1995; 81: 10878.[Medline]
16 Stokes DN, Robson N, Hutton P. Effect of diluting propofol on the incidence of pain on injection and venous sequalae. Br J Anaesth 1989; 62: 2023.
17 Chernin EL, Stewart JT, Smiler B. Stability of thiopental sodium and propofol in polypropylene syringes at 23 and 4°C. Am J Health Syst Pharm 1996; 53: 15769.
18 Lilley EM, Isert PR, Carasso ML, Kennedy RA. The effect of the addition of lignocaine on propofol emulsion stability. Anaesthesia 1996; 51: 8158.[Medline]
19 Sakuragi T, Yanagisawa K, Shirai Y, Dan K. Growth of Escherichia coli in propofol, lidocaine, and mixtures of propofol and lidocaine. Acta Anaesthesiol Scand 1999; 43: 4769.[Medline]
20 Wachowski I, Jolly DT, Hrazdil J, Galbraith JC, Greacen M, Clanachan AS. The growth of microorganisms in propofol and mixtures of propofol and lidocaine. Anesth Analg 1999; 88: 20912.
21 Crowther J, Hrazdil J, Jolly DT, Galbraith JC, Greacen M, Grace M. Growth of microorganisms in propofol, thiopental, and a 1:1 mixture of propofol and thiopental. Anesth Analg 1996; 82: 4758.[Abstract]
22 Chilvers M, Jones D, Rushmer J, Bignell S, Boots R, Prankerd R. Propofol-thiopentone admixture: recovery characteristics. Anaesth Intensive Care 1999; 27: 6019.[Medline]
This article has been cited by other articles:
![]() |
C. Reichert Beyond halothane: an update on pediatric anesthesia pharmacology Can J Anesth, June 1, 2003; 50(90001): R10 - 10. [Full Text] |
||||
![]() |
R. G. Cox Are children just little adults when it comes to propofol injection pain?/Les enfants ne sont-ils que de jeunes adultes face a la douleur caus'e par l'injection de propofol ? Can J Anesth, December 1, 2002; 49(10): 1016 - 1020. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |